<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<CLASS name="ANTICONVULSANT ENZYME INDUCERS" code="N03A-001" /></DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations and of the effectiveness of the theophylline due to increase of its hepatic metabolism by the inducer</DESCRIPTION>
<SEVERITY> Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="CIMETIDINE" rxcui="2541">
<ATC code="A02BA01" />
</DRUG>
</DRUG2>
<DESCRIPTION>With the cimetidine used in doses greater than or equal to 800 mg/day: increase of the theophyllinemia with risk of overdose (decrease of the metabolism of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="CIPROFLOXACIN" rxcui="2551">
<ATC code="J01MA02" />
<ATC code="S01AE03" />
<ATC code="S02AA15" />
<ATC code="S03AA07" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose, due to decrease of its hepatic metabolism by the ciprofloxacin.</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="CLARITHROMYCIN" rxcui="21212">
<ATC code="J01FA09" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of increase of the theophyllinemia, particularly with children</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="DIPYRIDAMOLE" rxcui="3521">
<ATC code="B01AC07" />
</DRUG>
</DRUG2>
<DESCRIPTION>With the dipyridamole by injection: reduction of the vasodilator effect of the dipyridamole by the theophylline</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="ENOXACIN" rxcui="3925">
<ATC code="J01MA04" />
</DRUG>
</DRUG2>
<DESCRIPTION>Overdose of theophylline due to substantial decrease of its metabolism</DESCRIPTION>
<SEVERITY>CONTRAINDICATION</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="ERYTHROMYCIN" rxcui="4053">
<ATC code="D10AF02" />
<ATC code="J01FA01" />
<ATC code="S01AA17" />
</DRUG>
</DRUG2>
<DESCRIPTION>Overdose of theophylline due to decrease of its hepatic elimination, more particularly dangerous with children</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="FLUCONAZOLE" rxcui="4450">
<ATC code="D01AC15" />
<ATC code="J02AC01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (decrease of the clearance of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="FLUVOXAMINE" rxcui="42355">
<ATC code="N06AB08" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with signs of overdose (decrease of the hepatic metabolism of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="HALOTHANE" rxcui="5095">
<ATC code="N01AB01" />
</DRUG>
</DRUG2>
<DESCRIPTION>Serious ventricular arrhythmias due to increase of cardiac sensitization</DESCRIPTION>
<SEVERITY>Not recommended</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<CLASS name="XANTHINE OXYDASE INHIBITORS" code="M04AA0" /></DRUG2>
<DESCRIPTION>In case of large doses of the inhibitor, increase of the plasma concentrations of theophylline due to inhibition of its metabolism</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<CLASS name="RITONAVIR BOOSTED PROTEASE INHIBITORS" code="J05AE-002" /></DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations of the theophylline, due to increase of its hepatic metabolism</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="JOSAMYCIN" rxcui="6084">
<ATC code="J01FA07" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of increase of the theophyllinemia, particularly with children</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="MEXILETINE" rxcui="6926">
<ATC code="C01BB02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (decrease of the hepatic metabolism of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="ST JOHNS WORT" rxcui="258326">
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations of the theophylline, by reason of the enzymatic inducer effect of the St Johns wort, with risk of reduction of effectiveness, even complete loss of the effect, which can have possibly serious consequences (onset of an obstructive pulmonary syndrome)</DESCRIPTION>
<SEVERITY>CONTRAINDICATION </SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="NORFLOXACIN" rxcui="7517">
<ATC code="J01MA06" />
<ATC code="S01AE02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (decrease of the metabolism of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="PEFLOXACIN" rxcui="7960">
<ATC code="J01MA03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (decrease of the metabolism of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="PENTOXIFYLLINE" rxcui="8013">
<ATC code="C04AD03" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (competition at the level of the hepatic metabolism of the theophylline) </DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="RIFAMPICIN" rxcui="9384">
<ATC code="J04AB02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Decrease of the plasma concentrations and of the effectiveness of the theophylline (increase of its metabolism by enzymatic induction) </DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="ROXITHROMYCIN" rxcui="9478">
<ATC code="J01FA06" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of increase of the theophyllinemia, particularly with children.</DESCRIPTION>
<SEVERITY>Take into account</SEVERITY>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="STIRIPENTOL" rxcui="37119">
<ATC code="N03AX17" />
</DRUG>
</DRUG2>
<DESCRIPTION>Possible increase of the theophyllinemia, with risk of overdose, due to inhibition of its hepatic metabolism</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="TIABENDAZOLE" rxcui="10450">
<ATC code="D01AC06" />
<ATC code="P02CA02" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose, due to decrease of the hepatic metabolism of the theophylline</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>512-THEOPHYLLINE-AND,-BY-EXTRAPOLATION,-AMINOPHYLLINE).html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<CLASS name="THEOPHYLLINE (AND, BY EXTRAPOLATION, AMINOPHYLLINE)" code="R03DA" /></DRUG1>
<DRUG2>
<DRUG name="TICLOPIDINE" rxcui="10594">
<ATC code="B01AC05" />
</DRUG>
</DRUG2>
<DESCRIPTION>Increase of the theophyllinemia with risk of overdose (decrease of the plasma clearance of the theophylline)</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
